 | • レポートコード：MRC23Q36755 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の骨移植代替物市場について調査・分析し、世界の骨移植代替物市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（同種移植、異種移植）、用途別セグメント分析（病院、診療所）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Medtronic PLC、DePuy Synthes Companies、ServicesIn Stryker、Zimmer Biomet、Smith & Nephew plc、SeaSpine、AlloSource、Bioventus、MTF Biologics、Orthofix HoldingsInc.などが含まれています。世界の骨移植代替物市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、骨移植代替物市場規模を推定する際に考慮しました。本レポートは、骨移植代替物の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、骨移植代替物に関するビジネス上の意思決定に役立てることを目的としています。 ・骨移植代替物市場の概要 - 製品の定義 - 骨移植代替物のタイプ別セグメント - 世界の骨移植代替物市場規模：タイプ別分析（同種移植、異種移植） - 骨移植代替物の用途別セグメント - 世界の骨移植代替物市場規模：用途別分析（病院、診療所） - 世界の骨移植代替物市場規模予測（2018年-2029年） - 骨移植代替物の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 骨移植代替物市場の競争状況およびトレンド ・骨移植代替物の地域別市場規模 - 北米の骨移植代替物市場規模（2018年-2029年） - アメリカの骨移植代替物市場規模（2018年-2029年） - ヨーロッパの骨移植代替物市場規模（2018年-2029年） - アジア太平洋の骨移植代替物市場規模（2018年-2029年） - 中国の骨移植代替物市場規模（2018年-2029年） - 日本の骨移植代替物市場規模（2018年-2029年） - 韓国の骨移植代替物市場規模（2018年-2029年） - インドの骨移植代替物市場規模（2018年-2029年） - オーストラリアの骨移植代替物市場規模（2018年-2029年） - 中南米の骨移植代替物市場規模（2018年-2029年） - 中東・アフリカの骨移植代替物市場規模（2018年-2029年） ・タイプ別セグメント：同種移植、異種移植 - 世界の骨移植代替物のタイプ別販売量（2018年-2023年） - 世界の骨移植代替物のタイプ別売上（2018年-2023年） - 世界の骨移植代替物のタイプ別価格 ・用途別セグメント：病院、診療所 - 世界の骨移植代替物の用途別販売量（2018年-2023年） - 世界の骨移植代替物の用途別売上（2018年-2023年） - 世界の骨移植代替物の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Medtronic PLC、DePuy Synthes Companies、ServicesIn Stryker、Zimmer Biomet、Smith & Nephew plc、SeaSpine、AlloSource、Bioventus、MTF Biologics、Orthofix HoldingsInc. ・産業チェーンと販売チャネルの分析 - 骨移植代替物産業チェーン分析 - 骨移植代替物の主要原材料 - 骨移植代替物の販売チャネル - 骨移植代替物のディストリビューター - 骨移植代替物の主要顧客 ・骨移植代替物市場ダイナミクス - 骨移植代替物の業界動向 - 骨移植代替物市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Bone Graft Alternatives market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Bone Graft Alternatives is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Bone Graft Alternatives is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Bone Graft Alternatives include Medtronic PLC, DePuy Synthes Companies, ServicesIn Stryker, Zimmer Biomet, Smith & Nephew plc, SeaSpine, AlloSource, Bioventus and MTF Biologics, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bone Graft Alternatives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bone Graft Alternatives.
The Bone Graft Alternatives market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bone Graft Alternatives market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bone Graft Alternatives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Medtronic PLC
DePuy Synthes Companies
ServicesIn Stryker
Zimmer Biomet
Smith & Nephew plc
SeaSpine
AlloSource
Bioventus
MTF Biologics
Orthofix HoldingsInc.
Segment by Type
Allograft
Xenograft
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bone Graft Alternatives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bone Graft Alternatives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Bone Graft Alternatives Market Overview
1.1 Product Overview and Scope of Bone Graft Alternatives
1.2 Bone Graft Alternatives Segment by Type
1.2.1 Global Bone Graft Alternatives Market Value Comparison by Type (2023-2029)
1.2.2 Allograft
1.2.3 Xenograft
1.3 Bone Graft Alternatives Segment by Application
1.3.1 Global Bone Graft Alternatives Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Bone Graft Alternatives Market Size Estimates and Forecasts
1.4.1 Global Bone Graft Alternatives Revenue 2018-2029
1.4.2 Global Bone Graft Alternatives Sales 2018-2029
1.4.3 Global Bone Graft Alternatives Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Bone Graft Alternatives Market Competition by Manufacturers
2.1 Global Bone Graft Alternatives Sales Market Share by Manufacturers (2018-2023)
2.2 Global Bone Graft Alternatives Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Bone Graft Alternatives Average Price by Manufacturers (2018-2023)
2.4 Global Bone Graft Alternatives Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Bone Graft Alternatives, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bone Graft Alternatives, Product Type & Application
2.7 Bone Graft Alternatives Market Competitive Situation and Trends
2.7.1 Bone Graft Alternatives Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bone Graft Alternatives Players Market Share by Revenue
2.7.3 Global Bone Graft Alternatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bone Graft Alternatives Retrospective Market Scenario by Region
3.1 Global Bone Graft Alternatives Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Bone Graft Alternatives Global Bone Graft Alternatives Sales by Region: 2018-2029
3.2.1 Global Bone Graft Alternatives Sales by Region: 2018-2023
3.2.2 Global Bone Graft Alternatives Sales by Region: 2024-2029
3.3 Global Bone Graft Alternatives Global Bone Graft Alternatives Revenue by Region: 2018-2029
3.3.1 Global Bone Graft Alternatives Revenue by Region: 2018-2023
3.3.2 Global Bone Graft Alternatives Revenue by Region: 2024-2029
3.4 North America Bone Graft Alternatives Market Facts & Figures by Country
3.4.1 North America Bone Graft Alternatives Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Bone Graft Alternatives Sales by Country (2018-2029)
3.4.3 North America Bone Graft Alternatives Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bone Graft Alternatives Market Facts & Figures by Country
3.5.1 Europe Bone Graft Alternatives Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Bone Graft Alternatives Sales by Country (2018-2029)
3.5.3 Europe Bone Graft Alternatives Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bone Graft Alternatives Market Facts & Figures by Country
3.6.1 Asia Pacific Bone Graft Alternatives Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Bone Graft Alternatives Sales by Country (2018-2029)
3.6.3 Asia Pacific Bone Graft Alternatives Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Bone Graft Alternatives Market Facts & Figures by Country
3.7.1 Latin America Bone Graft Alternatives Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Bone Graft Alternatives Sales by Country (2018-2029)
3.7.3 Latin America Bone Graft Alternatives Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bone Graft Alternatives Market Facts & Figures by Country
3.8.1 Middle East and Africa Bone Graft Alternatives Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Bone Graft Alternatives Sales by Country (2018-2029)
3.8.3 Middle East and Africa Bone Graft Alternatives Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bone Graft Alternatives Sales by Type (2018-2029)
4.1.1 Global Bone Graft Alternatives Sales by Type (2018-2023)
4.1.2 Global Bone Graft Alternatives Sales by Type (2024-2029)
4.1.3 Global Bone Graft Alternatives Sales Market Share by Type (2018-2029)
4.2 Global Bone Graft Alternatives Revenue by Type (2018-2029)
4.2.1 Global Bone Graft Alternatives Revenue by Type (2018-2023)
4.2.2 Global Bone Graft Alternatives Revenue by Type (2024-2029)
4.2.3 Global Bone Graft Alternatives Revenue Market Share by Type (2018-2029)
4.3 Global Bone Graft Alternatives Price by Type (2018-2029)
5 Segment by Application
5.1 Global Bone Graft Alternatives Sales by Application (2018-2029)
5.1.1 Global Bone Graft Alternatives Sales by Application (2018-2023)
5.1.2 Global Bone Graft Alternatives Sales by Application (2024-2029)
5.1.3 Global Bone Graft Alternatives Sales Market Share by Application (2018-2029)
5.2 Global Bone Graft Alternatives Revenue by Application (2018-2029)
5.2.1 Global Bone Graft Alternatives Revenue by Application (2018-2023)
5.2.2 Global Bone Graft Alternatives Revenue by Application (2024-2029)
5.2.3 Global Bone Graft Alternatives Revenue Market Share by Application (2018-2029)
5.3 Global Bone Graft Alternatives Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Medtronic PLC
6.1.1 Medtronic PLC Corporation Information
6.1.2 Medtronic PLC Description and Business Overview
6.1.3 Medtronic PLC Bone Graft Alternatives Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Medtronic PLC Bone Graft Alternatives Product Portfolio
6.1.5 Medtronic PLC Recent Developments/Updates
6.2 DePuy Synthes Companies
6.2.1 DePuy Synthes Companies Corporation Information
6.2.2 DePuy Synthes Companies Description and Business Overview
6.2.3 DePuy Synthes Companies Bone Graft Alternatives Sales, Revenue and Gross Margin (2018-2023)
6.2.4 DePuy Synthes Companies Bone Graft Alternatives Product Portfolio
6.2.5 DePuy Synthes Companies Recent Developments/Updates
6.3 ServicesIn Stryker
6.3.1 ServicesIn Stryker Corporation Information
6.3.2 ServicesIn Stryker Description and Business Overview
6.3.3 ServicesIn Stryker Bone Graft Alternatives Sales, Revenue and Gross Margin (2018-2023)
6.3.4 ServicesIn Stryker Bone Graft Alternatives Product Portfolio
6.3.5 ServicesIn Stryker Recent Developments/Updates
6.4 Zimmer Biomet
6.4.1 Zimmer Biomet Corporation Information
6.4.2 Zimmer Biomet Description and Business Overview
6.4.3 Zimmer Biomet Bone Graft Alternatives Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zimmer Biomet Bone Graft Alternatives Product Portfolio
6.4.5 Zimmer Biomet Recent Developments/Updates
6.5 Smith & Nephew plc
6.5.1 Smith & Nephew plc Corporation Information
6.5.2 Smith & Nephew plc Description and Business Overview
6.5.3 Smith & Nephew plc Bone Graft Alternatives Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Smith & Nephew plc Bone Graft Alternatives Product Portfolio
6.5.5 Smith & Nephew plc Recent Developments/Updates
6.6 SeaSpine
6.6.1 SeaSpine Corporation Information
6.6.2 SeaSpine Description and Business Overview
6.6.3 SeaSpine Bone Graft Alternatives Sales, Revenue and Gross Margin (2018-2023)
6.6.4 SeaSpine Bone Graft Alternatives Product Portfolio
6.6.5 SeaSpine Recent Developments/Updates
6.7 AlloSource
6.6.1 AlloSource Corporation Information
6.6.2 AlloSource Description and Business Overview
6.6.3 AlloSource Bone Graft Alternatives Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AlloSource Bone Graft Alternatives Product Portfolio
6.7.5 AlloSource Recent Developments/Updates
6.8 Bioventus
6.8.1 Bioventus Corporation Information
6.8.2 Bioventus Description and Business Overview
6.8.3 Bioventus Bone Graft Alternatives Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bioventus Bone Graft Alternatives Product Portfolio
6.8.5 Bioventus Recent Developments/Updates
6.9 MTF Biologics
6.9.1 MTF Biologics Corporation Information
6.9.2 MTF Biologics Description and Business Overview
6.9.3 MTF Biologics Bone Graft Alternatives Sales, Revenue and Gross Margin (2018-2023)
6.9.4 MTF Biologics Bone Graft Alternatives Product Portfolio
6.9.5 MTF Biologics Recent Developments/Updates
6.10 Orthofix HoldingsInc.
6.10.1 Orthofix HoldingsInc. Corporation Information
6.10.2 Orthofix HoldingsInc. Description and Business Overview
6.10.3 Orthofix HoldingsInc. Bone Graft Alternatives Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Orthofix HoldingsInc. Bone Graft Alternatives Product Portfolio
6.10.5 Orthofix HoldingsInc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bone Graft Alternatives Industry Chain Analysis
7.2 Bone Graft Alternatives Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bone Graft Alternatives Production Mode & Process
7.4 Bone Graft Alternatives Sales and Marketing
7.4.1 Bone Graft Alternatives Sales Channels
7.4.2 Bone Graft Alternatives Distributors
7.5 Bone Graft Alternatives Customers
8 Bone Graft Alternatives Market Dynamics
8.1 Bone Graft Alternatives Industry Trends
8.2 Bone Graft Alternatives Market Drivers
8.3 Bone Graft Alternatives Market Challenges
8.4 Bone Graft Alternatives Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer